Health
Mixed results for arthritis drug repurposed as Covid-19 treatment – Yahoo News Australia
A trio of new studies published in JAMA Internal Medicine on Tuesday examining the efficacy of an arthritis drug against Covid-19 showed inconsistent results.
A trio of new studies published in JAMA Internal Medicine on Tuesday examining the efficacy of an arthritis drug against Covid-19 showed inconsistent results.
Tocilizumab has been used by doctors since the start of the pandemic with the hope of tamping down an abnormal immune response known as a “cytokine storm” that causes severe organ damage in some hospitalized Covid-19 patients.
Unlike steroids, which suppress the immune system more broadly, tocilizumab blocks a particular signaling protei…
-
Noosa News18 hours agoMeasles alert: Australia Zoo, Hospital ED, Sushi Hub, Holey Moley Mini Golf and train stations among QLD infection sites
-
Business18 hours ago1 ASX dividend stock down 43% I’d buy right now
-
Noosa News18 hours agoBanana farmers still salvaging fruit four weeks after ex-Tropical Cyclone Alfred
-
Business22 hours agoBattle of the ASX ETFs: Why has VGS outperformed VTS this year?